Your browser doesn't support javascript.
loading
Novel methods for pregnancy drug safety surveillance in the FDA Sentinel System.
Suarez, Elizabeth A; Nguyen, Michael; Zhang, Di; Zhao, Yueqin; Stojanovic, Danijela; Munoz, Monica; Liedtka, Jane; Anderson, Abby; Liu, Wei; Dashevsky, Inna; Cole, David; DeLuccia, Sandra; Menzin, Talia; Noble, Jennifer; Maro, Judith C.
Afiliación
  • Suarez EA; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.
  • Nguyen M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Zhang D; Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Zhao Y; Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Stojanovic D; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Munoz M; Division of Pharmacovigilance, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Liedtka J; Division of Pediatric and Maternal Health, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Anderson A; Division of Urology, Obstetrics and Gynecology, Center for Drug and Evaluation Research, US Food and Drug Administration, Beltsville, Maryland, USA.
  • Liu W; Division of Epidemiology, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Dashevsky I; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.
  • Cole D; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.
  • DeLuccia S; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.
  • Menzin T; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.
  • Noble J; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.
  • Maro JC; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.
Pharmacoepidemiol Drug Saf ; 32(2): 126-136, 2023 Feb.
Article en En | MEDLINE | ID: mdl-35871766
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resultado del Embarazo Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Screening_studies Límite: Female / Humans / Infant / Newborn / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resultado del Embarazo Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Screening_studies Límite: Female / Humans / Infant / Newborn / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido